Showing 1 - 4 results of 4 for search 'Changju Qu', query time: 0.02s
Refine Results
-
1
Efficacy and safety of chimeric antigen receptor T cell therapy in relapsed/refractory diffuse large B-cell lymphoma with different HBV status: a retrospective study from a single... by Danqing Kong, Danqing Kong, Nana Ping, Nana Ping, Xin Gao, Rui Zou, Peng Wang, Peng Wang, Depei Wu, Depei Wu, Zhengming Jin, Zhengming Jin, Changju Qu, Changju Qu
Published 2023-05-01
Article -
2
-
3
Circulating tumor DNA determining hyperprogressive disease after CAR-T therapy alarms in DLBCL: a case report and literature review by Jiajie He, Jiajie He, Jiajie He, Rui Zou, Rui Zou, Rui Zou, Liqing Kang, Liqing Kang, Lingzi Yu, Lingzi Yu, Lingzi Yu, Peng Wang, Peng Wang, Yang Shao, Junheng Liang, Depei Wu, Depei Wu, Zhengming Jin, Zhengming Jin, Changju Qu, Changju Qu
Published 2023-11-01
Article -
4
Decitabine-primed tandem CD19/CD22 CAR-T therapy in relapsed/refractory diffuse large B-cell lymphoma patients by Changju Qu, Changju Qu, Rui Zou, Rui Zou, Rui Zou, Peng Wang, Peng Wang, Qian Zhu, Qian Zhu, Liqing Kang, Liqing Kang, Nana Ping, Nana Ping, Fan Xia, Hailing Liu, Danqing Kong, Danqing Kong, Lei Yu, Lei Yu, Depei Wu, Depei Wu, Zhengming Jin, Zhengming Jin
Published 2022-08-01
Article